Antiy PTA-mobile vs ImmuniWeb® Neuron Mobile: Side-by-Side Comparison (2026)

Antiy PTA-mobile

Mid-market and enterprise security teams handling high-volume Android app intake will benefit most from Antiy PTA-mobile's ability to monitor 200+ dynamic behaviors across 26 categories in a single sandbox run, capturing network traffic, file artifacts, and UI state without manual case work. The hybrid deployment model supports both server-based processing for large app batches and portable device carriers for field analysis, making it practical for carriers and regional security ops. Skip this if your organization needs upstream static analysis as a primary control; Antiy's strength is post-deployment behavioral visibility, not catching issues before apps ship.

ImmuniWeb® Neuron Mobile

Mobile app teams in startups and mid-market companies need ImmuniWeb® Neuron Mobile because it catches vulnerabilities in both Android and iOS builds without requiring source code access, letting you scan third-party SDKs and obfuscated code that static analyzers miss. The AI-driven DAST component handles runtime behavior testing across both platforms from a single cloud console, which cuts the typical two-tool sprawl in half. Skip this if you're an enterprise already committed to heavyweight SAST platforms with dedicated mobile modules; Neuron trades some configuration depth for speed and is built for teams that need results in days, not quarters.